Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
ACS Nano|July 31, 2012
Robust surface doping of Bi2Se3 by rubidium intercalationMarco Bianchi, Richard C Hatch, Zheshen Li, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 4, 2015
Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R)Holger Nef, Jens Wiebe, Stefan Achenbach, et al.
Minerva Medica|June 9, 2023
Very long-term outlook of acute coronary syndromes after percutaneous coronary intervention with implantation of polymer-free versus durable-polymer new-generation drug-eluting stentsFrancesco Versaci, Sebastian Kufner, Salvatore Cassese, et al.
The International Journal of Cardiovascular Imaging|August 22, 2021
Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trialHimanshu Rai, Fernando Alfonso, Michael Maeng, et al.
European Heart Journal|December 7, 2018
Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trialRobert A Byrne, Fernando Alfonso, Simon Schneider, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2014
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registryDavide Capodanno, Tommaso Gori, Holger Nef, et al.
Journal of Cardiovascular Translational Research|June 30, 2025
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-Eluting Stent Implantation or Drug-Coated Balloon Angioplasty According to Neointima Morphology in Drug-Eluting Stent REstenosis 5: Rationale and Design of the ISAR-DESIRE 5 TrialFiorenzo Simonetti, Felix Voll, Fernando Alfonso, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 27, 2022
Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosisNejva Nano, Alp Aytekin, Gjin Ndrepepa, et al.
JACC. Cardiovascular Interventions|February 16, 2016
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA RegistriesCorrado Tamburino, Piera Capranzano, Tommaso Gori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2016
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registryToru Naganuma, Antonio Colombo, Maciej Lesiak, et al.
Pageof 12